USPTO serial 78860689
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane Donnelly
DIANE DONNELLY VON MALTITZ, DERENBERG, KUNIN, JANSSEN &60 E 42ND ST RM 4410NEW YORK, NY 10165-0133UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | BIOLOGICAL PRODUCTS, NAMELY, HALF-LIFE EXTENDED PRODUCTS, NAMELY, ANTIBODIES, ANTIBODY FRAGMENTS, PROTEINS, CHIMERIC PROTEINS, DRUG CONJUGATES AND ENZYMES, FOR USE IN RESEARCH AND DEVELOPMENT OF PHARMACEUTICALS AND FOR MANUFACTURE OF PHARMACEUTICALS | ACTIVE | — |
| 005 | BIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES; BIOLOGICAL PRODUCTS, NAMELY, A DRUG DELIVERY SYSTEM COMPRISING ANTIBODIES OR ANTIBODY FRAGMENTS WHICH EXTEND THE EFFECT OF A WIDE VARIETY OF THERAPEUTIC AGENTS, FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; PHARMACEUTICAL PRODUCTS, NAMELY, ALLERGY MEDICATIONS, PAIN MEDICATION, ACNE MEDICATION, ADRENAL HORMONE PREPARATIONS, ANALGESICS, AN AESTHETICS FOR SURGICAL AND NON-SURGICAL USE, ANTACIDS, ANTI-ARRHYTHMICS, ANTIBACTERIAL PHARMACEUTICALS, ANTIBIOTICS, ANTICOAGULANTS, ANTI-CONVULSANTS, ANTIDEPRESSANTS, ANTIDIABETIC PREPARATIONS, ANTI-EMETICS, ANTIHISTAMINES, ANTIHYPERTENSIVES, ANTI-PARASITIC, ANTISEPTICS, ANTI-TOXIC SERA, ANTI-VIRAL, ANTI-ARTHRITIC COMPOSITIONS AND PREPARATIONS, ANTI-CANCER PREPARATIONS, ANTI-COUGH PREPARATIONS, ANTI-DERMOINFECTIVES, ANTI-DIABETIC PHARMACEUTICALS, ANTI-INFECTIVES, ANTI-INFLAMMATORIES, ANTI-SARCOMA PREPARATIONS, ANTI-VENIN, ASPIRIN PREPARATIONS , ANTI- BACTERIAL AND BACTERIOLOGICAL PREPARATIONS FOR MEDICAL PURPOSES, BETA BLOCKERS, BRONCHIAL DILATORS, BURN RELIEF MEDICATION, CARDIOVASCULAR PHARMACEUTICALS, CENTRAL NERVOUS SYSTEM STIMULANTS, CHEMOTHERAPEUTICS, CHLORAMPHENICOL PREPARATIONS, CHOLESTEROL REDUCERS, CHONDROITIN PREPARATIONS, COLD SORE TREATMENT AND/ OR PROPHYLAXIS PREPARATIONS, CONTRACEPTIVE PREPARATIONS, COUGH TREATMENT AND/ OR PROPHYLAXIS PREPARATIONS, DECONGESTANTS, DERMATOLOGICAL PHARMACEUTICAL PRODUCTS, DIAPHORETICS, DIETARY SUPPLEMENTS, DIURETICS, DRUG DELIVERY AGENTS CONSISTING OF COMPOUNDS THAT FACILITATE DELIVERY OF A WIDE RANGE OF PHARMACEUTICALS, EMETICS, EMMENAGOGUES, ERYTHROMYCIN PREPARATIONS, FERTILITY ENHANCEMENT PREPARATIONS, FOOD SUPPLEMENTS, GASTRO-INTESTINAL TREATMENT AND/ OR PROPHYLAXIS PREPARATIONS, GERMICIDES, GLAUCOMA AGENTS, HAIR GROWTH STIMULANTS, HEADACHE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, HAEMORRHOID TREATMENT AND/ OR PROPHYLAXIS PREPARATIONS, HORMONE PREPARATIONS, HYDROCORTISONE PREPARATIONS, HYPNOTICS, PHARMACEUTICALS FOR TREATMENT AND/ OR PROPHYLAXIS OF ANAPHYLACTIC REACTIONS, INSULIN PREPARATIONS, LACTAGOGUES, MEDICAL DIAGNOSTIC REAGENTS, MEDICATED MOUTH CARE AND TREATMENT PREPARATIONS, MEDICATED SKIN HAIR PREPARATIONS, MEDICATED HAIR CARE PREPARATIONS, MIGRAINE TREATMENT AND/OR PROPHYLAXIS PREPARATIONS, MIXED ANTIBIOTIC PREPARATIONS, MIXED VITAMIN PREPARATIONS, MOTION SICKNESS TREATMENT PREPARATIONS, MUSCLE RELAXANTS, NAIL FUNGUS TREATMENT AND/ OR PROPHYLAXIS PREPARATIONS, NASAL SPRAY PREPARATIONS, NAUSEA TREATMENT AND/ OR PROPHYLAXIS PREPARATIONS, OPHTHALMIC PREPARATIONS,OPHTHALMOLOGIC PREPARATIONS, PAIN RELIEF MEDICATION, PANCREAS HORMONE PREPARATIONS, ORAL CONTRACEPTIVES, PARASITICIDES FOR MEDICAL USE, PENICILLIN PREPARATIONS, PHARMACEUTICAL ANTI-MISSILE-COLD PREPARATIONS, PHARMACEUTICAL ANTI-ALLERGIC PREPARATIONS AND SUBSTANCES, PHARMACEUTICALS FOR THE TREATMENT OF ERECTILE DYSFUNCTION, ANTICOAGULANTS, ANTIDEPRESSANTS, APPETITE SUPPRESSANTS, ANTI-OBESITY PREPARATIONS, PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/OR PROPHYLAXIS OF GOUT, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF HEART RHYTHM DISORDERS, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF INFECTIOUS DISEASES, PHARMACEUTICAL PREPARATIONS ACTING ON THE CENTRAL NERVOUS SYSTEM, PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT AND/OR PROPHYLAXIS OF GASTRO-INTESTINAL DISEASES, PHARMACEUTICAL PREPARATIONS FOR INHALATION FOR THE TREATMENT AND/OR PROPHYLAXIS OF PULMONARY HYPERTENSION, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF CHRONIC PULMONARY DISEASE, PHARMACEUTICAL PREPARATIONS FOR OCULAR ORINTRAOCULAR SURGERY, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF HORMONAL DISORDERS AND THE PREVENTION OF OSTEOPOROSIS, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF ALLERGIC RHINITIS AND ASTHMA, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/ OR PROPHYLAXIS OF DIABETES, PHARMACEUTICAL PREPARATIONS FOR TREATING AND/ OR PROPHYLAXIS OF SKIN DISORDERS, PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY, PHARMACEUTICAL PREPARATIONS FOR WOUNDS, PHARMACEUTICAL PREPARATIONS FOR USE IN UROLOGY, BLOOD CLOTTING AID AND DELIVERY SYSTEMS FOR USE IN HUMAN MEDICINE, PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF EYE DISEASES AND CONDITIONS, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR CHILOASMA, PHARMACEUTICAL PRODUCTS AND PREPARATIONS FOR PREVENTING SKIN BLEMISHES DURING PREGNANCY, PHARMACEUTICAL PRODUCTS FOR OPHTHALMOLOGICAL USE, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF BONE DISEASES, PHARMACEUTICAL PRODUCTS FOR THE TREATMENT AND/ OR PROPHYLAXIS OF VIRAL AND INFECTIOUS DISEASES, FOR THE TREATMENT AND/ OR PROPHYLAXIS OF CANCER, PHARMACEUTICAL PRODUCTS FOR TREATING AND/ OR PROPHYLAXIS OF RESPIRATORY DISEASES AND ASTHMA, LIPID LOWERING AGENTS, PSYCHO TROPICS, PITUITARY HORMONE PREPARATIONS, PREPARATIONS FOR THE SUPPRESSION OF HORMONES, PREPARATIONS FOR TREATING AND/OR PROPHYLAXIS OF COLDS, RADIATION SICKNESS TREATING AGENTS, SEDATIVES, STEROIDS, MEDICATIONS FOR USE IN WEIGHT REDUCTION PROGRAMMES, STREPTOMYCIN PREPARATIONS, SYNTHETIC NARCOTICS, SYNTHETIC PEPTIDES FOR PHARMACEUTICAL PURPOSES, TETRACYCLINE PREPARATIONS, THIOLUTIN PREPARATIONS, THREONINE PREPARATIONS, TRANQUILISERS, TUMOUR SUPPRESSING AGENTS, VACCINES, PAIN RELIEF MEDICATION, ALL CONTAINING ANTIBODIES OR ANTIBODY FRAGMENTS FOR MEDICAL USE AND FOR USE IN MEDICAL TREATMENT; MEDICAL PREPARATIONS, NAMELY, ANTIBODIES, ANTIBODY FRAGMENTS, PROTEINS, CHIMERIC PROTEINS AND ENZYMES FOR TREATMENT OF PAIN, CENTRAL NERVOUS SYSTEM, INFLAMMATORY, RESPIRATORY, NEOPLASTIC, AUTO IMMUNE, INFECTION, NEUROLOGICAL, CARDIOVASCULAR, AND GASTROINTESTINAL DISEASES AND CONDITIONS, AND CANCER | ACTIVE | — |
| 042 | RESEARCH AND DEVELOPMENT SERVICES PERFORMED FOR OTHERS IN THE FIELDS OF DRUG DISCOVERY, DRUG DISCOVERY PRODUCTS, PHARMACEUTICALS, MEDICINAL DIAGNOSTICS, AND BIOLOGICAL PRODUCTS; PHARMACEUTICAL AND BIOLOGICAL PRODUCT DEVELOPMENT CONSULTATION; BIO TECHNICAL RESEARCH, CONSULTANCY AND TESTING; LABORATORY RESEARCH AND DEVELOPMENT SERVICES RELATING TO THE PRODUCTION OF ANTIBODIES | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 17, 2009 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 15, 2009 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 28, 2008 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 28, 2008 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 28, 2008 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 16, 2008 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 16, 2008 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 16, 2008 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 16, 2008 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 19, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 19, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2008 | PAPER RECEIVED | — | |
| Feb 5, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2007 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Nov 23, 2007 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Nov 23, 2007 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Nov 20, 2007 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 18, 2007 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 18, 2007 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 27, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Apr 27, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2007 | ALIE | ASSIGNED TO LIE | — |
| Mar 28, 2007 | PAPER RECEIVED | — | |
| Sep 19, 2006 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 19, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2006 | NWAP | NEW APPLICATION ENTERED | — |